×
Customize
?
Start
Cancer Types
Quick Links
Events
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Treatment for patients with bladder cancer is moving away from VEGF-targeted therapies toward immune checkpoint inhibition, according to one expert.
Katie Kosko
A mother and daughter share their personal journey with breast cancer to help inspire others facing a life-altering diagnosis.
Conor Killmurray
From the first child born to a patient with cancer from an egg matured in a lab to women with breast cancer taking to the runway for New York Fashion Week, here’s what is making headlines in the cancer space this week.
More
Voices
Jane Biehl PhD
A heartwarming story reminds one cancer survivor about the good people in the world that sometimes feels overwhelmingly negative.
Kathy Latour
When people think of caregivers, they often think of adults taking care of their elderly family members, but that is not the reality for many adolescents and young people who are forced into distressful situations when loved ones are diagnosed with cancer.
Steve Rubin
This time around, newfound joy and passion have added a different layer to Scanxiety.
More
CURE Connections®
Participants reflect on the benefits and effects of chemotherapy-free treatment for chronic lymphocytic leukemia (CLL).
Nathan Ferguson discusses why he pushed for chemotherapy-free treatment for chronic lymphocytic leukemia (CLL).
Perspectives on how the standard treatment of chronic lymphocytic leukemia (CLL) has shifted from chemotherapy to novel approaches.
More
Videos
Nancy Lin, M.D.
A recent study looking at data from three clinical trials involving Nerlynx shows promise for the future of treating patients with HER-2 positive breast cancer who develop CNS metastases.
Jonathan Rosenberg, M.D.
The results of a phase 2 study looking at Padcev and Keytruda combination therapy for patients with metastatic urothelial cancer shows promise with a 73% response that did not differ for a patient’s PDL1 status.
Amir Khan, MD
The incidence of colorectal and gastric cancers has risen for younger patients, and many of them share ethnic and socioeconomic disparities as well.
More
Podcasts
Jessica Skarzynski
In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Lainie Jones, who has found her purpose in helping others after being diagnosed with five separate primary cancers before the age of 35 because of a rare genetic condition that predisposes her to develop the disease.
Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with Bishoy Tadros, who went on to break barriers after he was diagnosed with acute lymphoblastic leukemia at the age of 3 and immigrated to the United States from Egypt to receive treatment.
Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with a survivor on two very rare types of cancer, called pheochromocytoma and paraganglioma, and why more research behind these two diseases can help put together the pieces of the cancer puzzle.
More
Recipes
Rachel Wong, RD, CSO, LD
Dive into fall with a nutritious and versatile winter squash.
Jessica Skarzynski
We’re ending our #CURESummerSnacktime series with a raspberry mint smoothie recipe that’s sure to cool you down as we enter the last days of summer!
Jessica Skarzynski
This avocado and herb recipe is packed with flavor and health benefits.
More
